429
Views
2
CrossRef citations to date
0
Altmetric
Review

Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors

, ORCID Icon, &
Pages 379-395 | Received 24 May 2017, Accepted 19 Dec 2017, Published online: 27 Dec 2017

References

  • Jang SH, Wientjes MG, Lu D, et al. Drug delivery and transport to solid tumors. Pharm Res. 2003;20:1337–1350.
  • Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004;14:198–206.
  • Caraglia M, Marra M, Misso G, et al. Tumour-specific uptake of anti-cancer drugs: the future is here. Curr Drug Metab. 2012;13:4–21.
  • Ruoslahti E, Bhatia SN, Sailor MJ, et al. Targeting of drugs and nanoparticles to tumors. J Cell Biol. 2010;188:759–768.
  • Agarwal R, Jurney P, Raythatha M, et al. Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models. Adv Healthc Mater. 2015;4:2269–2280.
  • Van Der Greef J, Mcburney RN. Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov. 2005;4(12):961–967.
  • Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653–664.
  • Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583–592.
  • Park JH, Von Maltzahn G, Zhang L, et al. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv Mater. 2008;20:1630–1635.
  • Iyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812–818.
  • Ernsting MJ, Murakami M, Roy A, et al. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172(3):782–794.
  • Ramanujan S, Pluen A, McKee TD. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J. 2002;83(3):1650–1660.
  • Xiao K, Li Y, Luo J, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32:3435–3446.
  • Lieleg O, Baumgartel RM, Bausch AR, et al. Selective filtering of particles by the extracellular matrix: an electrostatic bandpass. Biophys J. 2009;97:1569–1577.
  • Nomura T, Koreeda K, Yamashita F, et al. Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm Res. 1998;15(1):128–132.
  • Sadzuka Y, Hirotsu S, Hirota S, et al. Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11. Cancer Lett. 1998;127:99–106.
  • Chung TH, Wu SH, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959–2966.
  • Osaka T, Nakanishi T, Shanmugam S, et al. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloid Surface B. 2009;71:325–330.
  • Zhang K, Fang H, Chen Z, et al. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. Bioconjugate Chem. 2008;19:1880–1887.
  • Lee H, Hoang B, Fonge H, et al. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Pharm Res. 2010;27:2343–2355.
  • Nel AE, Madler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8:543–557.
  • Lamberti M, Zappavigna S, Sannolo N. Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. Expert Opin Drug Del. 2014;11(7):1087–1101.
  • Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2:249–255.
  • Tanaka T, Mangala LS, Vivas-Mejia PE, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res. 2010;70:3687–3696.
  • Van De Ven AL, Kim P, Haley O, et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release. 2012;158:148–155.
  • Adriani G, De Tullio MD, Ferrari M, et al. The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials. 2012;33:5504–5513.
  • Smith BR, Ghosn EE, Rallapalli H, et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol. 2014;9:481–487.
  • Yang K, Ma YQ. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol. 2010;5:579–583.
  • Agarwal R, Singh V, Jurney P, et al. Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. P Natl Acad Sci USA. 2013;110:17247–17252.
  • Shen S, Gu T, Mao D, et al. Synthesis of nonspherical mesoporous silica ellipsoids with tunable aspect ratios for magnetic assisted assembly and gene delivery. Chem Mater. 2013;24:230–235.
  • Shukla S, Eber FJ, Nagarajan AS, et al. The impact of aspect ratio on the biodistribution and tumor homing of rigid soft-matter nanorods. Adv Healthc Mater. 2015;4:874–882.
  • Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008;269:57–66.
  • Toy R, Peiris PM, Ghaghada KB, et al. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine. 2014;9:121–134.
  • Gentile F, Chiappini C, Fine D, et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J. Biomech. 2008;41:2312–2318.
  • Lee SY, Ferrari M, Decuzzi P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology. 2009;20:495101.
  • Chariou PL, Lee KL, Pokorski JK, et al. Diffusion and uptake of tobacco mosaic virus as therapeutic carrier in tumor tissue: effect of nanoparticle aspect ratio. J Phys Chem B. 2016;120:6120–6129.
  • Cifuentes-Rius A, Boase NR, Font I, et al. In vivo fate of carbon nanotubes with different physicochemical properties for gene delivery applications. Acs Appl Mater Inter. 2017;9:11461–11471.
  • Anselmo AC, Zhang M, Kumar S, et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis and targeting. Acs Nano. 2015;9(3):3169–3177.
  • Key J, Palange AL, Gentile F, et al. Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors. Acs Nano. 2015;9(12):11628–11641.
  • Gabizon A, Goren D, Horowitz AT, et al. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev. 1997;24(2):337–344.
  • Lazarovits J, Chen YY, Sykes EA, et al. Nanoparticle-blood interactions: the implications on solid tumour targeting. Chem Commun. 2015;51:2756–2767.
  • Dobrovolskaia MA, Aggarwal P, Hall JB. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5:487–495.
  • Owens III DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93–102.
  • Wang J, Sui M, Fan W, et al. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab. 2010;11:129–141.
  • Shimkin MB. The molecular basis of cancer. Jama. 1996;275(6):492–493.
  • Heldin CH, Rubin K, Pietras K, et al. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4:806–813.
  • Holback H, Yeo Y. Intratumoral drug delivery with nanoparticulate carriers. Pharm Res. 2011;28:1819–1830.
  • Netti PA, Berk DA, Swartz MA, et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 2000;60(9):2497–2503.
  • Lauk S, Zietman A, Skates S, et al. Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res. 1989;49(16):4557.
  • Stylianopoulos T, Poh M, Insin N, et al. Diffusion of particles in the extracellular matrix the effect of repulsive electrostatic interactions. Biophys J. 2010;99(5):1342–1349.
  • Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650.
  • Lee CG, Heijn M, Di TE, et al. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 2000;60(60):5565–5570.
  • Willett CG, Boucher Y, Di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10:145–147.
  • Shaffer SA, Baker-Lee C, Kennedy J, et al. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother Pharmacol. 2007;59:537–548.
  • Alizadeh D, Zhang L, Hwang J, et al. Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine. 2010;6:382–390.
  • Truong NP, Whittaker MR, Mak CW, et al. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12(1):129–142.
  • Huang X, Li L, Liu T, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5:5390–5399.
  • Macdonald IC, Schmidt EE, Groom AC. The high splenic hematocrit: a rheological consequence of red cell flow through the reticular meshwork. Microvasc Res. 1991;42(1):60–76.
  • Ruggiero A, Villa CH, Bander E, et al. Paradoxical glomerular filtration of carbon nanotubes. Proc Natl Acad Sci U S A. 2010;107(27):51–69.
  • Decuzzi P, Lee S, Bhushan B, et al. A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng. 2005;33:179–190.
  • Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials. 2006;27:5307–5314.
  • Godin B, Chiappini C, Srinivasan S, et al. Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater. 2012;22(20):4225–4235.
  • Merkel TJ, Jones SW, Herlihy KP, et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci U S A. 2011;108(2):586–591.
  • Serda RE, Gu J, Bhavane RC, et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials. 2009;30:2440–2448.
  • Park J, Butler JE. Analysis of the migration of rigid polymers and nanorods in a rotating viscometric flow. Macromolecules. 2010;43:2535–2543.
  • Zhou Z, Ma X, Jin E, et al. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials. 2013;34(22):5722–5735.
  • Huang X, Peng X, Wang Y, et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano. 2010;4:5887–5896.
  • Cai S, Vijayan K, Cheng D, et al. Micelles of different morphologies–advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery. Pharm Res. 2007;24:2099–2109.
  • Christian DA, Cai S, Garbuzenko OB, et al. Flexible filaments for in vivo imaging and delivery persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol Pharm. 2009;6(5):1343–1352.
  • Shukla S, Ablack AL, Wen AM, et al. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. Mol Pharm. 2013;10:33–42.
  • Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A. 2006;103:3357–3362.
  • Matsumoto Y, Nichols JW, Toh K, et al. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nat Nanotechnol. 2016;11:533–538.
  • Miller MA, Chandra R, Cuccarese MF, et al. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci Transl Med. 2017;9:392.
  • Lee TR, Greene MS, Jiang Z, et al. Quantifying uncertainties in the microvascular transport of nanoparticles. Biomech Model Mechanobiol. 2014;13:515–526.
  • Lee TR, Choi M, Kopacz AM, et al. On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci Rep. 2013;3:2079.
  • Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release. 2010;141:320–327.
  • Park J, Estrada A, Schwartz JA, et al. Intra-organ biodistribution of gold nanoparticles using intrinsic two-photon induced photoluminescence. Lasers Surg Med. 2010;42:630–639.
  • Gormley AJ, Greish K, Ray A. Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. Int J Pharm. 2011;415:315–318.
  • Huang X, Elsayed IH, Qian W. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128(6):2115–2120.
  • Akiyama Y, Mori T, Katayama Y. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release. 2009;139:81–84.
  • Song J, Yang X, Jacobson O, et al. Ultrasmall gold nanorod vesicles with enhanced tumor accumulation and fast excretion from the body for cancer therapy. Adv Mater. 2015;27(33):4910.
  • Sun H, Chen B, Jiao X, et al. Solvothermal synthesis of tunable electroactive magnetite nanorods by controlling the side reaction. J Phys Chem C. 2012;116(9):5476–5481.
  • Das R, Alonso J, Porshokouh ZN. Tunable high aspect ratio iron oxide nanorods for enhanced hyperthermia. J Phys Chem C. 2016;120(18):10086–10093.
  • Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73:2412–2417.
  • Geng Y, Ahmed F, Bhasin N, et al. Visualizing worm micelle dynamics and phase transitions of a charged diblock copolymer in water. J Phys Chem B. 2005;109(9):3772.
  • Shukla S, Wen AM, Ayat NR, et al. Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. Nanomedicine. 2014;9:221–235.
  • Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68:6652–6660.
  • Cheng Q, Blais MO, Harris GM, et al. PLGA-carbon nanotube conjugates for intercellular delivery of caspase-3 into osteosarcoma cells. Plos One. 2013;8(8):e81947.
  • Liu Z, Winters M, Holodniy M, et al. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl. 2007;46:2023–2027.
  • Antonelli A, Serafini S, Menotta M, et al. Improved cellular uptake of functionalized single-walled carbon nanotubes. Nanotechnology. 2010;21:425101.
  • Yang S, Guo W, Lin Y, et al. Biodistribution of pristine single-walled carbon nanotubes in vivo. J Phys Chem C. 2007;111(48):17761–17764.
  • Robinson JT, Hong G, Liang Y, et al. In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. J Am Chem Soc. 2012;134:10664–10669.
  • Xu R, Zhang G, Mai J, et al. An injectable nanoparticle generator enhances delivery of cancer therapeutics. Nat Biotechnol. 2016;34:414–418.
  • Chauhan VP, Popovic Z, Chen O, et al. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew Chem Int Ed Engl. 2011;50:11417–11420.
  • Stylianopoulos T, Diop-Frimpong B, Munn LL, et al. Diffusion anisotropy in collagen gels and tumors the effect of fiber network orientation. Biophys J. 2010;99(99):3119–3128.
  • Thurber GM, Schmidt MM, Wittrup KD. Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. Adv Drug Deliv Rev. 2008;60:1421–1434.
  • Kim Y, Dalhaimer P, Christian DA, et al. Polymeric worm micelles as nano-carriers for drug delivery. Nanotechnology. 2005;16(7):S484–91.
  • Geng Y, Discher DE. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J. Am. Chem. Soc. 2005;127(37):12780–12781.
  • Yi H, Ghosh D, Ham MH, et al. M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett. 2012;12:1176–1183.
  • Wang Y, Bahng JH, Che Q, et al. Anomalously fast diffusion of targeted carbon nanotubes in cellular spheroids. Acs Nano. 2015;9(8):8231–8238.
  • Kostarelos K, Lacerda L, Pastorin G, et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol. 2007;2:108–113.
  • Kam NWE, Liu Z, Dai H, et al. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Edit. 2006;118:591–595.
  • Cordoyiannis G, Rao Jampani VS, Kralj S, et al. Different modulated structures of topological defects stabilized by adaptive targeting nanoparticles. Soft Matter. 2013;9:3956.
  • Karatairi E, Rozic B, Kutnjak Z, et al. Nanoparticle-induced widening of the temperature range of liquid-crystalline blue phases. Phys Rev E. 2010;81:041703.
  • Rozic B, Tzitzios V, Karatairi E, et al. Theoretical and experimental study of the nanoparticle-driven blue phase stabilisation. Eur Phys J E. 2011;34:17.
  • Fallyn W, Campbell RG. The use of nanoparticles in electroanalysis: an updated review. Compton Anal Bioanal Chem. 2010;396:241–259.
  • Allaker RP. The use of nanoparticles to control oral biofilm formation. J Dent Res. 2010;89(11):1175–1186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.